Clean the site with an alcohol swab
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Stimulates collagen, glycosaminoglycans & elastin pathways
Despite being relatively small, BPC-157 has demonstrated remarkably diverse healing properties in preclinical research (5)
It may help with neurodegenerative conditions or cognitive optimization
Depending on your situation, your consultation may include a discussion of: Your sleep history Stress levels Hormonal health Nutrition Existing medical conditions Lab testing Whether peptide therapy is appropriate, or whether another approach may better address your concerns Sometimes the best next step isnt a peptide at all
